SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001999371-24-004298
Filing Date
2024-04-01
Accepted
2024-04-01 16:35:16
Documents
14
Period of Report
2024-04-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp_8k-040124.htm   iXBRL 8-K 23184
2 PRESS RELEASE ex99-01.htm EX-99.01 130071
  Complete submission text file 0001999371-24-004298.txt   349917

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20240401.xsd EX-101.SCH 2991
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20240401_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20240401_pre.xml EX-101.PRE 22343
17 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8k-040124_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 24810022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)